Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Patient Characteristics Associated with Medication Adherence.
The effects of identification with a support group on the mental health of people with multiple sclerosis.
The myelin mutants as models to study myelin repair in the leukodystrophies.
TNFRSF1A polymorphisms and MS: Statistical signals transform into pathogenetic mechanisms.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.
Tremor in multiple sclerosis: The intriguing role of the cerebellum.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Few patients with neurodegenerative disorders require spinal surgery.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis.
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Identifying and treating pain caused by MS.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Pages
« first
‹ previous
…
332
333
334
335
336
337
338
339
340
…
next ›
last »